India, Jan. 21 -- Anteris Technologies Global Corp. (AVR,AVR.AX), a medical technology company, on Tuesday, priced its public offering of 34.78 million shares at $5.75 per share, raising expected gross proceeds of about $200 million before fees and expenses.
The offering is expected to close on January 22.
All shares are being granted underwriters a 30-day option to purchase up to an additional 5.22 million shares at the offering price.
Further, the company agreed to sell up to $90 million of stock to Medtronic plc (MDT) through a wholly owned subsidiary in a private placement priced at the public offering price.
The private placement is subject to a minimum purchase equal to 16.0% and a maximum of 19.99% of Anteris' shares outstanding ...